Search

You searched for "learning"

855 results found

Urological trauma – part 2

1 November 2015 | | URO - Trauma & Emergency
Part 1 of this topic is available here. Case 1 A 29-year-old male was attacked and kicked in his left flank. He presented to the emergency department with left flank pain and frank haematuria. He remained haemodynamically stable. 1. What...

Paediatric urology: what you need to know for FRCS (Urol)

4 March 2025 | | URO - Paediatrics
Lianne Pickett, Urology ST5 at Great Ormond Street Hospital (GOSH), and Ms Neetu Kumar, Consultant Paediatric Urological Surgeon at GOSH, provide expert insights into the key aspects of paediatric urology. Curriculum Paediatric urology contributes one of the eight stations of...
European Urology journal front cover.

Defining adjuvant, consolidative, and salvage treatment after RP

2 July 2025 | | URO - Urologic Oncology
The most common oncologic outcome following radical prostatectomy (RP) for localised prostate cancer is achieving undetectable prostate-specific antigen (PSA) levels (<0.1 ng/ml), indicating an absence of detectable disease. However, the landscape of RP is shifting as active surveillance becomes the...
European Urology journal front cover.

Are standard repeat biopsies during active surveillance for prostate cancer still necessary?

2 July 2025 | | URO - Urologic Oncology
Active surveillance (AS) has emerged as a key strategy for managing low-risk prostate cancer (PCa), offering an alternative to immediate treatment. Initially, AS relied on prostate specific antigen (PSA) testing, digital rectal examinations (DRE), and systematic biopsies. Early studies using...

The microbial syndicate: dysbiosis and origins of recurrent UTIs

2 July 2025 | | URO - Basic Science Research, URO - Infection
Traditional dogma held that urine was sterile. However, recent molecular studies have revealed an underground microbial community, known as the urinary microbiome or ‘urobiome’ [1]. Far from being harmful, this community of microorganisms helps modulate immune responses, regulate inflammation, and...

Occupational tumours of the urinary tract: The work of Denis Poole-Wilson

1 July 2017 | | URO - Technology, URO - Urologic Oncology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I said I would be taking you to the...

Priapism

7 January 2021 | | URO - Andrology
Priapism is defined as an abnormally persistent erection lasting greater than four hours, not associated with sexual desire [1]. Although relatively uncommon with an incidence of 1.5 per 100,000 [2], priapism has a risk of complications which can have a...

Inguino-scrotal sarcomas

1 May 2019 | | URO - Uroradiology, URO - Urologic Oncology, URO - Andrology
A sarcoma is a malignant tumour that originates from mesenchymal cells such as adipose tissue, bone, cartilage and smooth muscle. Although these tumours histologically do not originate from the urogenital tract, urologists are often involved in their diagnosis and management...

Saints preserve us!

5 May 2021 | | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website www.baus.org.uk. A saint is a holy person; the word derives from the Latin word...

Things in a place they should not be!

12 September 2023 | | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). I think we all have stories of objects inserted into the urethra and...

A short history of nephrectomy

1 November 2016 | | URO - Technology, URO - Urologic Oncology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I promised to tell you about removing kidneys, by...

The assessment and medical treatment of LUTS secondary to BPH

1 November 2016 | URO - Functional / Reconstructive Urology
The term benign prostatic hyperplasia (BPH) describes prostate enlargement due to non-cancerous processes. Several aetiological mechanisms are involved, including hormonal and vascular alterations; abnormal regulation of apoptosis; and prostatic inflammation, which may stimulate cellular proliferation. With ageing, prostate enlargement can...